DS
MRVI icon

David Shaw’s Maravai LifeSciences MRVI Stock Holding History

David Shaw’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-119,123
Closed -$990K – 4697
2024
Q3 		$990K Sell
119,123
-364,437
-75% -$3.15M ﹤0.01% 3278
2024
Q2 		$3.46M Sell
483,560
-1,119,676
-70% -$9.67M ﹤0.01% 2148
2024
Q1 		$13.9M Buy
1,603,236
+370,737
+30% +$2.51M 0.01% 1150
2023
Q4 		$8.07M Buy
1,232,499
+463,246
+60% +$2.99M 0.01% 1523
2023
Q3 		$7.69M Buy
769,253
+200,971
+35% +$2.21M 0.01% 1467
2023
Q2 		$7.06M Sell
568,282
-582,061
-51% -$7.86M 0.01% 1624
2023
Q1 		$16.1M Sell
1,150,343
-288,361
-20% -$4.14M 0.02% 1025
2022
Q4 		$20.6M Buy
1,438,704
+621,160
+76% +$9.78M 0.02% 896
2022
Q3 		$20.9M Buy
817,544
+330,568
+68% +$8.29M 0.02% 819
2022
Q2 		$13.8M Buy
486,976
+106,595
+28% +$3.38M 0.02% 1143
2022
Q1 		$13.4M Buy
380,381
+431
+0.1% +$14.4K 0.01% 1333
2021
Q4 		$15.9M Sell
379,950
-264,852
-41% -$10.7M 0.01% 1253
2021
Q3 		$31.6M Buy
644,802
+308,421
+92% +$15M 0.03% 758
2021
Q2 		$14M Buy
+336,381
New +$13M 0.01% 1234

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

David Shaw's MRVI Position: Q4 2024 in Review

David Shaw sold out of Maravai LifeSciences (MRVI) in Q4 2024, closing a stake of 119,123 shares — an estimated $990K sold.

David Shaw first reported a position in MRVI in Q2 2021 and held it in 14 quarters. The position peaked at $31.6M in Q3 2021. 185 funds tracked by Wall St. Rank hold MRVI as of Q4 2024.

  • David Shaw reported no remaining Maravai LifeSciences position as of Q4 2024 after selling out during the quarter.
  • David Shaw sold 119,123 Maravai LifeSciences shares in Q4 2024, an estimated $990K.
  • David Shaw first reported a position in Maravai LifeSciences in Q2 2021 and held it in 14 quarters.
  • David Shaw's Maravai LifeSciences position peaked at $31.6M in Q3 2021.
  • 185 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2024.

Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.